Sun Hydraulics (SNHY) Touches $67.59 High on Jan, 14; 15 Analysts Covering Spark Therapeutics, Inc. (ONCE)

January 14, 2018 - By Dolores Ford

The stock of Sun Hydraulics Corporation (NASDAQ:SNHY) reached all time high today, Jan, 14 and still has $73.67 target or 9.00% above today’s $67.59 share price. This indicates more upside for the $1.83B company. This technical setup was reported by Barchart.com. If the $73.67 PT is reached, the company will be worth $164.70M more. The stock increased 0.52% or $0.35 during the last trading session, reaching $67.59. About 66,629 shares traded. Sun Hydraulics Corporation (NASDAQ:SNHY) has risen 43.99% since January 14, 2017 and is uptrending. It has outperformed by 27.29% the S&P500.

Among 22 analysts covering Spark Therapeutics (NASDAQ:ONCE), 15 have Buy rating, 1 Sell and 6 Hold. Therefore 68% are positive. Spark Therapeutics had 53 analyst reports since August 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cantor Fitzgerald on Friday, August 25. As per Tuesday, October 10, the company rating was maintained by Cantor Fitzgerald. Chardan Capital Markets initiated it with “Neutral” rating and $45.0 target in Wednesday, December 23 report. The rating was maintained by RBC Capital Markets on Monday, December 11 with “Buy”. The rating was initiated by Evercore with “Buy” on Tuesday, April 12. The company was maintained on Monday, October 5 by Roth Capital. The rating was initiated by Stifel Nicolaus with “Buy” on Friday, September 2. The company was maintained on Tuesday, October 10 by Stifel Nicolaus. The firm earned “Buy” rating on Wednesday, October 25 by RBC Capital Markets. On Thursday, June 23 the stock rating was maintained by Cantor Fitzgerald with “Buy”. See Spark Therapeutics, Inc. (NASDAQ:ONCE) latest ratings:

03/01/2018 Broker: Cowen & Co Rating: Buy New Target: $85.0 Maintain
02/01/2018 Broker: BMO Capital Markets Rating: Buy New Target: $67.0 Maintain
14/12/2017 Broker: Goldman Sachs Rating: Hold New Target: $58.0 Downgrade
13/12/2017 Broker: Bernstein Rating: Buy New Target: $71.0 Maintain
12/12/2017 Broker: Wedbush Rating: Hold Upgrade
12/12/2017 Broker: Leerink Swann Rating: Hold New Target: $49.0 Downgrade
12/12/2017 Broker: UBS Rating: Hold New Target: $51.0 Downgrade
11/12/2017 Broker: RBC Capital Markets Rating: Buy New Target: $68.0 Maintain
11/12/2017 Broker: J.P. Morgan Rating: Buy New Target: $92.0 Maintain
11/12/2017 Broker: Cantor Fitzgerald Rating: Buy New Target: $105.0 Maintain

Analysts await Sun Hydraulics Corporation (NASDAQ:SNHY) to report earnings on February, 26. They expect $0.33 earnings per share, up 175.00% or $0.21 from last year’s $0.12 per share. SNHY’s profit will be $8.93 million for 51.20 P/E if the $0.33 EPS becomes a reality. After $0.43 actual earnings per share reported by Sun Hydraulics Corporation for the previous quarter, Wall Street now forecasts -23.26% negative EPS growth.

Since August 8, 2017, it had 0 buys, and 4 selling transactions for $3.38 million activity. 20,000 shares were sold by KOSKI CHRISTINE L, worth $946,651.

Investors sentiment decreased to 1.08 in Q3 2017. Its down 0.62, from 1.7 in 2017Q2. It fall, as 16 investors sold Sun Hydraulics Corporation shares while 33 reduced holdings. 24 funds opened positions while 29 raised stakes. 21.44 million shares or 0.65% less from 21.58 million shares in 2017Q2 were reported. 7,087 were reported by Aviance Prtnrs Lc. Deprince Race & Zollo Inc owns 37,356 shares or 0.05% of their US portfolio. 2,590 are held by Tower Rech Capital Limited Liability Com (Trc). Penn Mngmt has invested 0.04% in Sun Hydraulics Corporation (NASDAQ:SNHY). Morgan Stanley has 0% invested in Sun Hydraulics Corporation (NASDAQ:SNHY). Thompson Siegel And Walmsley Ltd Liability reported 0% of its portfolio in Sun Hydraulics Corporation (NASDAQ:SNHY). New York-based Oppenheimer Asset Inc has invested 0% in Sun Hydraulics Corporation (NASDAQ:SNHY). Aqr Mgmt Limited Liability Company stated it has 5,805 shares or 0% of all its holdings. Jefferies Grp Inc Limited Liability Co holds 7,897 shares or 0% of its portfolio. Pub Employees Retirement Systems Of Ohio stated it has 29,439 shares. Baldwin Brothers Inc Ma stated it has 10,132 shares. Manufacturers Life Insurance Communication The accumulated 18,117 shares or 0% of the stock. Bbva Compass Financial Bank has invested 0.06% in Sun Hydraulics Corporation (NASDAQ:SNHY). Aperio Gp Limited Liability invested 0% in Sun Hydraulics Corporation (NASDAQ:SNHY). Geode Limited Co holds 0% or 220,251 shares.

Sun Hydraulics Corporation designs, makes, and sells screw-in cartridge valves, manifolds, and integrated fluid power packages and subsystems used in hydraulic systems to industrial and mobile clients worldwide. The company has market cap of $1.83 billion. The firm operates in two divisions, Hydraulics and Electronics. It has a 57.18 P/E ratio. The Company’s screw-in hydraulic cartridge valves and manifolds control force, speed, and motion as integral components in fluid power systems.

The stock decreased 2.61% or $1.41 during the last trading session, reaching $52.66. About 712,166 shares traded. Spark Therapeutics, Inc. (NASDAQ:ONCE) has risen 13.53% since January 14, 2017 and is uptrending. It has underperformed by 3.17% the S&P500.

Investors sentiment increased to 2.94 in 2017 Q3. Its up 1.13, from 1.81 in 2017Q2. It improved, as 17 investors sold Spark Therapeutics, Inc. shares while 19 reduced holdings. 46 funds opened positions while 60 raised stakes. 33.64 million shares or 23.59% more from 27.22 million shares in 2017Q2 were reported. Viking Glob Invsts Limited Partnership, Connecticut-based fund reported 243,140 shares. Wells Fargo Co Mn invested in 0.01% or 476,750 shares. Proshare Ltd Liability Corp has invested 0.02% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Td Asset Mgmt Incorporated has 0.01% invested in Spark Therapeutics, Inc. (NASDAQ:ONCE) for 80,151 shares. Eam Invsts Ltd Liability Com stated it has 0.33% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Alyeska Invest Gru Lp invested in 151,621 shares or 0.11% of the stock. Royal Retail Bank Of Canada invested 0% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Amalgamated Bancorp holds 3,397 shares. Jefferies Gru Ltd Liability Corporation owns 26,100 shares for 0.02% of their portfolio. Rockefeller Financial Service stated it has 0% in Spark Therapeutics, Inc. (NASDAQ:ONCE). Meeder Asset Management Inc has invested 0% of its portfolio in Spark Therapeutics, Inc. (NASDAQ:ONCE). Guggenheim Capital Limited Liability Co invested 0.01% of its portfolio in Spark Therapeutics, Inc. (NASDAQ:ONCE). Citadel Advisors Llc accumulated 13,623 shares. State Of Wisconsin Investment Board accumulated 16,000 shares or 0% of the stock. 16,416 are owned by Marshall Wace Llp.

Spark Therapeutics, Inc. focuses on the development of gene therapy products for patients suffering from debilitating genetic diseases. The company has market cap of $1.95 billion. The Company’s products include voretigene neparvovec, which is in Phase III clinical trial for the treatment of genetic blinding conditions called inherited retinal diseases caused by non sex-linked, autosomal recessive, or biallelic mutations in the RPE65 gene; and SPK-CHM that is in Phase I/II clinical trial for the treatment of choroideremia. It currently has negative earnings. The companyÂ’s products also comprise SPK-7001 that is in Phase 1/2 trial for choroideremia; SPK-9001, which is in Phase 1/2 trial for hemophilia B; and SPK-8011 that is in Phase 1/2 trial hemophilia A.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>